ATC Group: S03AA Antiinfectives

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of S03AA in the ATC hierarchy

Level Code Title
1 S Sensory organs
2 S03 Ophthalmological and otological preparations
3 S03A Antiinfectives
4 S03AA Antiinfectives

Group S03AA contents

Code Title
S03AA01 Neomycin
S03AA02 Tetracycline
S03AA03 Polymyxin B
S03AA04 Chlorhexidine
S03AA05 Hexamidine
S03AA06 Gentamicin
S03AA07 Ciprofloxacin
S03AA08 Chloramphenicol
S03AA30 Antiinfectives, combinations

Active ingredients in S03AA

Active Ingredient

Chloramphenicol is a broad spectrum antibiotic which has activity against many types of Gram-positive and Gram-negative bacteria. It acts by interfering with bacterial protein synthesis. Chloramphenicol is widely distributed in body tissues and fluids and enters the cerebrospinal fluid.

Chlorhexidine is an antimicrobial agent, active against a broad spectrum of Gram-positive and Gram-negative organisms, yeasts, fungi, opportunistic anaerobes and aerobes. Chlorhexidine is mainly a “membrane-acting” agent that destroys the outer membrane of the bacteria. It is inactive on bacterial spores unless the temperatures are high.

Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.

Gentamicin is usually bactericidal in action. Although the exact mechanism of action has not been fully elucidated, the drug appears to inhibit protein synthesis in susceptible bacteria by irreversibly binding to 30S ribosomal subunits.

Neomycin is an aminoglycoside antibiotic and acts by binding to polysomes, inhibiting protein synthesis and generating errors in the transcription of the genetic code.

Polymixin B is bactericidal against a wide range of gram negative bacilli. It exerts a bactericidal effect by binding to acid phospholipids in the cell wall and membranes of the bacterium, thereby rendering ineffective the osmotic barrier normally provided by the cell membrane.

Tetracyclines are taken up into sensitive bacterial cells by an active transport process. Once within the cell they bind reversibly to the 30S subunit of the ribosome, preventing the binding of aminoacyl transfer RNA and inhibiting protein synthesis and hence cell growth.

Related product monographs

Document Type Information Source  
 CILOXAN Eye drops, solution MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 CILOXAN Ointment MPI, US: SPL/Old FDA, National Drug Code (US)
 CILOXAN Ophthalmic solution MPI, US: SPL/Old FDA, National Drug Code (US)